rs755093676
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001492.6(GDF1):c.159C>T(p.Pro53Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000864 in 1,562,656 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000087 ( 1 hom. )
Consequence
GDF1
NM_001492.6 synonymous
NM_001492.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.655
Publications
0 publications found
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]
CERS1 Gene-Disease associations (from GenCC):
- progressive myoclonic epilepsy type 8Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-18870149-G-A is Benign according to our data. Variant chr19-18870149-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 539308.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.655 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDF1 | NM_001492.6 | c.159C>T | p.Pro53Pro | synonymous_variant | Exon 7 of 8 | ENST00000247005.8 | NP_001483.3 | |
CERS1 | NM_021267.5 | c.*428C>T | 3_prime_UTR_variant | Exon 7 of 8 | ENST00000623882.4 | NP_067090.1 | ||
GDF1 | NM_001387438.1 | c.159C>T | p.Pro53Pro | synonymous_variant | Exon 4 of 5 | NP_001374367.1 | ||
CERS1 | NM_001387440.1 | c.*428C>T | 3_prime_UTR_variant | Exon 7 of 7 | NP_001374369.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDF1 | ENST00000247005.8 | c.159C>T | p.Pro53Pro | synonymous_variant | Exon 7 of 8 | 1 | NM_001492.6 | ENSP00000247005.5 | ||
CERS1 | ENST00000623882.4 | c.*428C>T | 3_prime_UTR_variant | Exon 7 of 8 | 1 | NM_021267.5 | ENSP00000485308.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152092Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000129 AC: 23AN: 177702 AF XY: 0.000143 show subpopulations
GnomAD2 exomes
AF:
AC:
23
AN:
177702
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000872 AC: 123AN: 1410446Hom.: 1 Cov.: 34 AF XY: 0.000102 AC XY: 71AN XY: 696804 show subpopulations
GnomAD4 exome
AF:
AC:
123
AN:
1410446
Hom.:
Cov.:
34
AF XY:
AC XY:
71
AN XY:
696804
show subpopulations
African (AFR)
AF:
AC:
28
AN:
32948
American (AMR)
AF:
AC:
1
AN:
39314
Ashkenazi Jewish (ASJ)
AF:
AC:
27
AN:
24778
East Asian (EAS)
AF:
AC:
0
AN:
38520
South Asian (SAS)
AF:
AC:
1
AN:
80790
European-Finnish (FIN)
AF:
AC:
0
AN:
38350
Middle Eastern (MID)
AF:
AC:
4
AN:
5460
European-Non Finnish (NFE)
AF:
AC:
37
AN:
1091672
Other (OTH)
AF:
AC:
25
AN:
58614
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
12
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41544
American (AMR)
AF:
AC:
3
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5152
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
67994
Other (OTH)
AF:
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Oct 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.